1 / 5

R&I: Potential Analysis of Ebola drug & Vaccines Market 2020

Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. The report provides in-depth coverage of the ebola therapeutics and vaccines market including drivers, restraints and opportunities would help professionals to better understand market behavior. Detailed report at: http://www.reportsandintelligence.com/ebola-therapeutics-vaccines-market

VivianaRiley111
Download Presentation

R&I: Potential Analysis of Ebola drug & Vaccines Market 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020 No of pages: 55 Publish Date: September 2014

  2. Description Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests. Due to high mortality rate and unavailability of effective treatments, the pharmaceutical companies have big opportunities to explore. TekmiraPharmaceuticals, BioCryst Pharmaceutical Inc., Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical are some of the leading companies focusing on research activities to develop efficacious medicine for EVD. Additionally, the governments in the developed countries have also taken formidable steps to support the research activities for the development of EVD therapeutics by providing funding and floating favorable policies.  

  3. Key Benefits • This report offers the following benefits in particular: • To track commercial trends, major clinical trials and their status are pursued of closely • The report sheds light on the key events held in past years concerning the development of ebola viral disease therapeutics • Pin-point analysis of geographic segments helps to identify opportunities for growth within the ebola therapeutics and vaccines market • Porter’s Five Forces analysis examines the competitive structure of the ebola therapeutics and vaccines market and would assist market strategists in their respective decision making process

  4. Table Of Content Introduction Executive Summary Market Overview Forecaste Scenario Analysis Of Ebola Vaccines, 2013-2020, ($Million) Global Pipeline And Market Potential Analysis Of E-bola Therapeutic Vaccines Market By Geography, 2013 – 2020 Company Profiles Get full TOC at: http://www.reportsandintelligence.com/ebola-therapeutics-vaccines-market/table-of-contents

  5. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/ebola-therapeutics-vaccines-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related